Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting ; volume:49 ; number:8 ; day:13 ; month:7 ; year:2023 ; pages:966-976 ; date:8.2023
Intensive care medicine ; 49, Heft 8 (13.7.2023), 966-976, 8.2023

Creator: Greppmair, Sebastian
Brinkmann, Alexander
Roehr, Anka
Frey, Otto
Hagel, Stefan
Dorn, Christoph
Marsot, Amélie
El-Haffaf, Ibrahim
Zoller, Michael
Saller, Thomas
Zander, Johannes
Schatz, Lea Marie
Scharf, Christina
Briegel, Josef
Minichmayr, Iris K.
Wicha, Sebastian G.
Liebchen, Uwe

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00134-023-07154-0

URN: urn:nbn:de:101:1-2023110310171744601199

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Greppmair, Sebastian
Brinkmann, Alexander
Roehr, Anka
Frey, Otto
Hagel, Stefan
Dorn, Christoph
Marsot, Amélie
El-Haffaf, Ibrahim
Zoller, Michael
Saller, Thomas
Zander, Johannes
Schatz, Lea Marie
Scharf, Christina
Briegel, Josef
Minichmayr, Iris K.
Wicha, Sebastian G.
Liebchen, Uwe
SpringerLink (Online service)

Other Objects (12)

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin

Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling

Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing

Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan

Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients

Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology

Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin

Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling

Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing

Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan

Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients

Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology

Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin

Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling

Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing

Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan

Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients

Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology

Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin

Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling

Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing

Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan

Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients

Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology

Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin

Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling

Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing

Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan

Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients

Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology

Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin

Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling

Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing

Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population

Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis

Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan

Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care

Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients

Bayesian data assimilation and reinforcement learning for model-informed precision dosing in oncology

Novel approaches to improve model-informed precision dosing in haemophilia A and infectious diseases

Related objects

Reset password